Along this line, it was recently reported that conditional inactivation of DCC expression or invalidation of DCC‐induced apoptosis by introduction of a D1290N point mutation is, respectively associated with breast and colorectal tumor progression in two mutant mice models (Castets et al, 2012; Krimpenfort et al, 2012). This evidence concerns the gene DCC and colorectal neoplasm.